NCT04808128

Brief Summary

Quasi-experiment and Cross-sectional study, six-arm design protocol will be carried out. The study will be conducted under the Declaration of Helsinki. The current study will assess the effects of EDs consumption on the physiological and psychological responses of Israeli Arab adolescents. These effects will also be examined in association with the adolescent's plasma metabolite profiles. The study has five specific aims: (1) to assess the effects of ED consumption with or without a meal, on Israeli Arab adolescents glucose levels by using mixed meal tolerance test (MMTT) (2) to assess the effect of ED consumption with or without a meal on their blood pressure (3) to evaluate the association between ED consumption per day by the Israeli Arab adolescents and their nutritional status and habits (4) to examine for possible associations between Israeli Arab adolescents psychological status (i.e. mood and anxiety) and ED consumption per day (5) to examine for possible associations between ED and caffeine consumption and plasma metabolite profiles and, the subject's psychological status.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 22, 2021

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

March 22, 2021

Status Verified

March 1, 2021

Enrollment Period

6 months

First QC Date

March 11, 2021

Last Update Submit

March 17, 2021

Conditions

Keywords

Energy drinks (EDs)Blood pressure (BP)Glucose toleranceMetabolite profilesMoodAnxiety

Outcome Measures

Primary Outcomes (6)

  • Blood sugar change

    Change in blood sugar levels (mg/dL) will be measured with the mixed meal tolerance test (MMTT) five times - one time at baseline (before consuming the meal) and four times during the intervention (15, 30, 60 and 120 minutes after consuming the meal).

    First measurement at baseline, before consuming the meal, and four times during the intervention - 15, 30, 60 and 120 minutes after consuming the meal

  • Anxiety status

    Anxiety status will be measured one time during the intervention - 60 minutes after consuming the meal, with the SCARED-R questionnaire (Muris et al., 1999) in Arabic. SCARED-R is a self-report questionnaire which measures anxiety status in the last 3 months. Contains 41 statements (such as "I am nervous") in Likert scale of 0 ("Not True or Hardly Ever True") to 2 ("Very True or Often True"). A total score of ≥ 25 may indicate the presence of an Anxiety Disorder.

    During the intervention, 60 minutes after consuming the meal.

  • Mood change

    Mood change will be measured two times - one time at baseline (before consuming the meal) and another time during the intervention - 60 minutes after consuming the meal. Mood will be measured with the UMACL questionnaire (Matthews et al., 1990) in Arabic. UMACL is a self-report questionnaire which measures the current mood of the subject. Contains 29 statements (such as "I am happy"), in Likert scale of 1 ("absolutely") to 4 ("not at all"). The higher the score, the better the current mood is.

    First measurement at baseline, before consuming the meal, and another measurement during the intervention, 60 minutes after consuming the meal.

  • Insulin levels status

    Insulin levels status will be measured based on blood samples that will be taken from subjects during the intervention, 30-45 minutes after consuming the meal. Analysis will take place after the data collection stage.

    During the intervention, between 30-45 minutes after consuming the meal.

  • SCFA levels status

    SCFA levels status will be measured based on blood samples that will be taken from subjects during the intervention, 30-45 minutes after consuming the meal. Analysis will take place after the data collection stage.

    During the intervention, between 30-45 minutes after consuming the meal.

  • HR change

    Changes in heart rate (BPM) will be measured five times - First at baseline (before consuming the meal) and four times during the intervention - 15, 30, 60 and 120 minutes after consuming the meal.

    First measurement at baseline, before consuming the meal, and four times during the intervention - 15, 30, 60 and 120 minutes after consuming the meal

Secondary Outcomes (4)

  • BP change

    First measurement at baseline, before consuming the meal, and four times during the intervention - 15, 30, 60 and 120 minutes after consuming the meal

  • Life habits status

    During intervention, 60 minutes after consuming the meal.

  • Energy drinks consumption status

    During intervention, 60 minutes after consuming the meal.

  • Caffeine consumption frequency

    During intervention, 60 minutes after consuming the meal.

Study Arms (6)

Drink A + SC

EXPERIMENTAL

In t0 the group will receive 250 ml XL energy drink + 20 gr sucrose.

Other: Drink A + SC

Drink B + SC

ACTIVE COMPARATOR

In t0 the group will receive 250 ml Fanta soft drink + 20 gr sucrose.

Other: Drink B + SC

Drink C + SC

ACTIVE COMPARATOR

In t0 the group will receive 250 ml soda water + 47 gr sucrose.

Other: Drink C + SC

Drink A + CC

EXPERIMENTAL

In t0 the group will receive 250 ml XL energy drink + 20gr complex carbohydrates from one slice of bread (30g) and one spoon of hummus.

Other: Drink A + CC

Drink B + CC

ACTIVE COMPARATOR

In t0 the group will receive 250 ml Fanta soft drink + 20gr complex carbohydrates from one slice of bread (30g) and one spoon of hummus.

Other: Drink B + CC

Drink C + CC

ACTIVE COMPARATOR

In t0 the group will receive 250 ml soda water + 27gr sucrose + 20gr complex carbohydrates from one slice of bread (30g) and one spoon of hummus.

Other: Drink C + CC

Interventions

Consumption of energy drink that contains 80mg caffeine and 27g carbohydrates per 250ml together with simple carbohydrates.

Drink A + SC

Consumption of soft drink, non-caffeine drink that contains 27g carbohydrates per 250ml together with simple carbohydrates.

Drink B + SC

Consumption of soda water, non-caffeine and non-carbohydrate drink together with simple carbohydrates.

Drink C + SC

Consumption of energy drink that contains 80mg caffeine and 27g carbohydrates per 250ml together with complex carbohydrates.

Drink A + CC

Consumption of soft drink, non-caffeine drink that contains 27g carbohydrates per 250ml together with complex carbohydrates.

Drink B + CC

Consumption of soda water, non-caffeine and non-carbohydrate drink together with complex carbohydrates.

Drink C + CC

Eligibility Criteria

Age15 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Healthy
  • Israeli Arab adolescents
  • aged 14.5-17.5 years

You may not qualify if:

  • diabetes
  • hypoglycemic episodes
  • coronary heart disease, cardiac arrhythmia, secondary hypertension, structural heart lesions
  • hepatic or renal disorders
  • autonomic neuropathy
  • epilepsy
  • obstructive sleep apnea
  • migraines
  • caffeine intolerance
  • eating disorders or other mental disorders or those with prescribed psychiatric medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Vincent De Paul hospital

Nazareth, 16511, Israel

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Lili Nimri, Dr.

    Nutritional sciences Department Tel-Hai College

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lili Nimri, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2021

First Posted

March 22, 2021

Study Start

October 2, 2020

Primary Completion

April 1, 2021

Study Completion

October 1, 2022

Last Updated

March 22, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations